Evaluation of Thoracic Tumors With 18F-Fluorothymidine and 18F-Fluorodeoxyglucose-Positron Emission Tomography
- 1 February 2006
- Vol. 129 (2) , 393-401
- https://doi.org/10.1378/chest.129.2.393
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- [ 18 F]FLT PET for diagnosis and staging of thoracic tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell linesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell linesNuclear Medicine and Biology, 2002
- [18F]FLT; portrait of a proliferation markerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign VariantsRadioGraphics, 1999
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- Accelerated EM reconstruction in total-body PET: potential for improving tumour detectabilityPhysics in Medicine & Biology, 1994
- Performance Evaluation of the Positron Scanner ECAT EXACTJournal of Computer Assisted Tomography, 1992